1. Association of Cytoplasmic CXCR4 With Loss of Epithelial Marker and Activation of ERK1/2 and AKT Signaling Pathways in Non–Small-Cell Lung Cancer
   Nabil F. Saba et al, 2017, Clinical Lung Cancer CrossRef
2. Plasmacytoma in patients with multiple myeloma: morphology and immunohistochemistry
   Maiia V. Firsova et al, 2020, BMC Cancer CrossRef
3. Overexpression of CXCR4 promotes invasion and migration of non‑small cell lung cancer via EGFR and MMP‑9
   Jianhong Zuo et al, 2017, Oncology Letters CrossRef
4. Chemokines and NSCLC: Emerging role in prognosis, heterogeneity, and therapeutics
   Saumya Srivastava et al, 2022, Seminars in Cancer Biology CrossRef
5. Coexpression of EGFR and CXCR4 Predicts Poor Prognosis in Resected Pancreatic Ductal Adenocarcinoma
   Huanwen Wu et al, 2015, PLOS ONE CrossRef
6. Concomitant underexpression of TGFBR2 and overexpression of hTERT are associated with poor prognosis in cervical cancer
   Hui Yang et al, 2017, Scientific Reports CrossRef
7. Cyclin D1 Serves as a Poor Prognostic Biomarker in Stage I Gastric Cancer
   Se-Il Go et al, 2022, Current Issues in Molecular Biology CrossRef
8. Serum CEA Level Change and Its Significance Before and after Gefitinib Therapy on Patients with Advanced Non-small Cell Lung Cancer
   Hai-Feng Qin et al, 2013, Asian Pacific Journal of Cancer Prevention CrossRef
9. Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms
   Daniel Kaemmerer et al, 2015, Oncotarget CrossRef
10. The clinicopathological and prognostic value of CXCR4 expression in patients with lung cancer: a meta-analysis
    Liping Qiu et al, 2022, BMC Cancer CrossRef
11. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner
    Songping Xie et al, 2017, Oncology Reports CrossRef
12. Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy
    Weiqiang Zhou et al, 2019, Current Medicinal Chemistry CrossRef
13. CXCR4 over-expression and survival in cancer: A system review and meta-analysis
    Hongli Zhao et al, 2015, Oncotarget CrossRef
14. Reversion of tumor hepatocytes to normal hepatocytes during liver tumor regression in an oncogene transgenic zebrafish model
    Yan Li et al, 2019, Disease Models & Mechanisms CrossRef
15. Oncogenic roles and drug target of CXCR4/CXCL12 axis in lung cancer and cancer stem cell
    Zhidong Wang et al, 2016, Tumor Biology CrossRef
16. Somatostatin and CXCR4 expression patterns in adenocarcinoma and squamous cell carcinoma of the lung relative to small cell lung cancer
    Claudia Stumpf et al, 2018, Journal of Cancer Research and Clinical Oncology CrossRef
17. Ribosome induces transdifferentiation of A549 and H-111-TC cancer cell lines
    Mohammad Badrul Anam et al, 2021, Biochemistry and Biophysics Reports CrossRef
18. Flot-2 Expression Correlates with EGFR Levels and Poor Prognosis in Surgically Resected Non-Small Cell Lung Cancer
    Qiuyuan Wen et al, 2015, PLOS ONE CrossRef
19. Chemokines and their receptors in lung cancer progression and metastasis
    Zeng-hui Cheng et al, 2016, Journal of Zhejiang University-SCIENCE B CrossRef